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IS PROPHYLACTIC THERAPY FOR VARICES JUSTIFIED?
CAN THE FIRST VARICEAL BLEED BE PREDICTED?
ABSTRACT
The North Italian Endoscopic Club for the Study and Treatment of
Esophageal Varices. (1988) Prediction of the first variceal hemorrhage in
patients with cirrhosis of the liver and esophageal varices. A Prospective
Multicenter Study. The New England Journal of Medicine 319,983-989.
We conducted a prospective study of 321 patients with cirrhosis of the liver and
esophageal varices with no history ofbleeding to see whether a comprehensive analysis
of their clinical features and of the endoscopic appearances oftheir varices could help
to identify those at highest risk for bleeding. Varices were classified endoscopically as
suggested by the Japanese Research Society for Portal Hypertension. Patients were
followed for 1 to 38 months (median, 23), during which 85 patients (26.5 percent) bled.
Multiple regression analysis (Cox’s model) revealed that the risk of bleeding was
significantly related to the patient’s modified Child class (an index ofliver dysfunction
based on serum albumin concentration, bilirubin level, prothrombin time, and the
presence ofascites and encephalopathy), the size ofthe varices, and the presence ofred
wale markings (longitudinal dilated venules resembling whip marks) on the varices. A
prognostic index based on these variables was devised that enabled us to identify a
subset of patients with a one-year incidence of bleeding exceeding 65 percent. The
index was prospectively validated on an independent sample of 75 patients with
varices and no history of bleeding.
We conclude that our prognostic index, which identifies groups ofpatients with one-
year probabilities of bleeding ranging from 6 to 76 percent, can be used to identify
candidates for prophylactic treatment. (N Engl J Med 1988; 319;983-9)
PAPER DISCUSSION
In June 1979 the Japanese Research Society for Portal Hypertension met in Osaka
and drew up rules for the endoscopic classification ofvarices according to size, shape,
location, colour and colour signs1. Beppu and colleagues
2 retrospectively analysed
their endoscopic recordings on 172 patients and looked at the relationship between
endoscopic findings and the incidence of bleeding. On the basis of their results they
proposed a complicated discriminant equation as a means of predicting the
likelihood of non-bleeders becoming bleeders. However when the North Italian
group applied the Japanese formula to their patients, they obtained a gross over-
estimate of the risk of bleeding. Even high risk Japanese patients selected by
Inokuchi3 according to Beppu’s criteria had a less than 20 per cent chance ofbleeding
at one year. Paquet used endoscopic signs ofimpending haemorrhage together with
coagulation deficiencies to select out high risk patients for his trial of prophylactic
therapy. In the three year follow up period there was an exceptionally high rate of
bleeding in the control patients; two thirds experienced haemorrhage. Witzel and his
colleagues
5 reported that 57 per cent of their control patients bled in a twenty-five
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incidence of bleeding ranged from 35 per cent for small varices to 53 per cent for
medium varices and 83 per cent for large varices. In Koch and colleagues
’6
propylactic trial they again took all comers with varices and in the three year follow
up period only 30 per cent of their patients in the control arm bled. This fiure is
much closer to that reported in the United Kingdom by Hayes and colleagues’, who
found an 18 per cent incidence of bleeding in a follow up period of almost two years.
The figure for the Italian study is 26 per cent for a median follow up period of 23
months. Thus if only approximately 25 per cent are likely to survive the first
haemorrhage, prophylactic therapy is likely to benefit less than 10 per cent of all
patients.
The trials ofpropylactic shunts in the 1960’s failed to demonstrate an improvement
in survival for operated patients. However these trials suffered from the fact that the
clinicians had no means of selecting for the trial only those patients with a high risk
of bleeding. Thus in the control group only about 30 per cent of the patients actually
bled. In addition there was a significant initial operative mortality for shunt surgery.
The development of formulae for identifying patients at high risk of bleeding
together with the availability of sclerotherapy with its low mortality in the non
bleeding patient, has rekindled interest in prophylactic therapy. Harold Conn
8
pointed out that "as with a volcano, it is difficult to know when a varix will erupt".
However it would be useful ifwe could estimate the percentage risk of rupture for an
individual patient during the ensuing couple of years. The North Italian Endoscopic
Club (N.I.E.C.) for the study and treatment of oesophageal varices set out to see
whether endoscopy alone or in combination with clinical and biochemical data could
recognise prospectively patients with the highest risk of bleeding and hence the ones
who would benefit most from prophylactic therapy. In their introduction they refer
to a "40 per cent chance of dying of the initial bleeding episode" and quote in
evidence four references dating back as far as 1968; none of the series referred to had
used sclerotherapy. In most modern series sclerotherapy controls bleeding in over 90
per cent of patients with a hospital mortality usually well under 30 per cent9’10’11’12.
The possible use of prophylactic therapy must be seen against the background of
these more relevant figures. One would have to be able to identify a subset of patients
with a high risk of bleeding and then put them into a controlled trial which offers the
best available form of therapy to patients in the control group who subsequently
bleed. The problem of the early trials which advocated prophylactic sclerotherapy
was that this was not done and therefore the mortality in the control patients was
45 unacceptably high ’. Subsequent trials of prophylactic sclerotherapy have been less
3 14 enthusiastic The International Symposium on Prophylaxis of Variceal Bleeding
held in Munich in 1986 concluded that there was no justification for prophylactic
therapy other than in controlled trials15.
This multicentre study by the North Italian Endoscopic Club suggests that their
prognostic index could be used to identify candidates suitable for prophylactic
therapy. It enabled them to "identify a subset of patients with a one year incidence
of bleeding exceeding 65 per cent". However this subset was only 11 patients out of
321 studied (3.4 per cent), and they admit that using their formula "the number of
very high risk patients who can be identified with it is very small". Ofthe whole series
of 321 patients, 85 (26 per cent) developed upper gastro-intestinal bleeding during a
median follow up of 23 months. This represents 0.01 haemorrhage per patient per
month. Of the 85 who bled, only 53 had proven variceal bleeding. In the results
section, the paper states that "in the remaining 28 patients endocopy either could not252 HPB INTERNATIONAL
be performed, or was performed after bleeding had stopped", although in the
discussion it states that no endoscopy was performed on these 28 patients. They
assume that the majority of these non-endoscoped patients bled from varices and
take the liberty of including them in the percentage rates of bleeding given in Table
6. Since the point of the exercise is to identify patients that would benefit from
prophylactic therapy for varices, it is somewhat unsatisfactory to include a third of
the patients with no diagnosis of the source of bleeding.
In their initial assessment the authors used Beppu’s endoscopic scoring system
together with a number of clinical and biochemical variables. Following a series of
complicated mathematical and statistical calculations, they reduced the number of
variables considered most useful to three, namely, Child’s classification, variceal size
(three categories) and red wale markings (four categories). The advantage of using
these three variables is that they are simple, commonly used and less liable to
observor error than many of the criteria employed in the Japanese classification.
Their "pocket chart" gives an easy method of calculating the N.I.E.C. prognostic
index on the basis of scores obtained for the three variables. They then reduced the
rather complicated six-risk groups of Beppu’s classification down to three in a
prospective study of a further 75 patients. Of these 75 patients, 19 (25 per cent) bled
during "a short follow up". Where the N.I.E.C. index was less than 30, five of the 36
patients (14 per cent) bled, between 30 and 36 seven out of 20 bled (35 per cent) bled
and where the N.I.E.C. was greater than 36, seven out of 19 (37 per cent) bled. The
actual rate of bleeding in these patients studied prospectively was almost identical to
that predicted from the retrospective study. Of the 75 patients studied prospectively
less than 20 per cent scored over 30 on the N.I.E.C. index. This small subset of
patients are the ones most likely to benefit from prophylactic therapy but only a
multicentre trial could provide sufficient numbers to give an answer. This present
study suffers from being a multi-centre trial involving nine clinics and 56 clinicians.
Of the original 383 patients, 36 were excluded for various reasons, leaving 343 to
enter the study. However 26 patients failed to attend after the first endoscopy. The
potential follow up period was 24 to 38 months (median 23 months) and yet a further
59 patients were lost to follow up inside the 23-month period.
The struggle to find a formula to predict patients at high risk is commendable but
we have to agree with the authors’ own conclusions that "The N.I.E.C. index is not
ideal". Certainly if propylactic therapy is to be employed in the future, it will be
necessary to have some easily reproducible method of identifying patients at high
risk of variceal bleeding and this study provides the most useful formula to date.
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THE APPROACH TO CARCINOMA OF THE PROXIMAL HEPATIC DUCTS:
MORE RADICAL OR MORE CONSERVATIVE
ABSTRACT
S. Bengmark, H Ekberg, A. Evander, B. Klofver-Stahl and K-G. Tranberg (1988)
Major liver resection for hilar cholangiocarcinoma. Ann. Surg. 207;120-125.
Between 1968 and 1984 liver resection with curative attempt was performed in 22 patients with hilar
cholangiocarcinoma. Right lobectomy was performed in 4 patients, extended right lobectomy in 7,
left lobectomy in 8, and excision of the median segment of the left lobe (segment IV) in 3. Bilio-
enteric continuity was restored by hepatocholedochostomy in 17 patients and hepatojejunostomy in
4. (One patient had external transhepatic catheter drainage and no internal bile drainage).
Operative mortality rate was 27% and caused by excessive intraoperative bleeding, sepsis, or liver
insufficiency. Postoperative complications occurred in 57% of patients surviving the operation and
were due mainly to leakage from the hepatocholedochostomy. Median survival was 6 months, and
one third of the patients survived I year. Three patients survived 10 years and were among the four
patients in whom a tumor-free resection margin was obtained (one ofthem died in the postoperative
phase). It is concluded that resection of hilar cholangiocarcinoma may give long-term survival if a
free resection margin is obtained. The importance of a free resection margin indicates that surgery
should be aggressive and include liver resection.